Email this article 
Purulent Hydradenitis. Part II
- Authors: Rodionov A.N.1, Sobolev A.V.2, Skrek S.V.1,3, Wolkenstein P.4, Yunovidova A.A.3
-
Affiliations:
- North-Western State Medical University named after I. I. Mechnikov, Ministry of Health of the Russian Federation
- Research Institute of Medical Mycology named after P. N. Kashkin of the North-Western State Medical University named after I. I. Mechnikov, Ministry of Health of the Russian Federation
- The Pierre Wolkenstein French Dermatological Clinic
- Dermatological Service of the Henri Mondor University Hospital
- Issue: Vol 93, No 6 (2017)
- Pages: 41-46
- Section: SHORT COMMUNICATION
- URL: https://vestnikdv.ru/jour/article/view/351
- DOI: https://doi.org/10.25208/0042-4609-2017-93-6-41-46
- ID: 351
Cite item
Full Text
Abstract
Keywords
About the authors
A. N. Rodionov
North-Western State Medical University named after I. I. Mechnikov, Ministry of Health of the Russian Federation
Author for correspondence.
Email: fake@neicon.ru
д.м.н., профессор кафедры дерматовенерологии
Russian FederationA. V. Sobolev
Research Institute of Medical Mycology named after P. N. Kashkin of the North-Western State Medical Universitynamed after I. I. Mechnikov, Ministry of Health of the Russian Federation
Email: fake@neicon.ru
д.м.н., профессор кафедры
Russian FederationS. V. Skrek
North-Western State Medical University named after I. I. Mechnikov, Ministry of Health of the Russian Federation ;The Pierre Wolkenstein French Dermatological Clinic
Email: fake@neicon.ru
к.м.н., ассистент кафедры дерматовенерологии
Russian FederationP. Wolkenstein
Dermatological Service of the Henri Mondor University Hospital
Email: fake@neicon.ru
заведующий кафедрой, Дерматологическая служба университетского госпиталя Энри Мондор
FranceA. A. Yunovidova
The Pierre Wolkenstein French Dermatological Clinic
Email: anastasia.yunovidova@gmail.com
врач-дерматовенеролог Клиники кожных болезней Пьера Волькенштейна
Russian Federation
References
- Kurzen H., Kurokawa I., Jemec G. B. et al. What Causes Hidradenitis Suppurativa? Exp. Dermatol. 2008;17(5):455–456.
- Jemec G. B. The Symptomatology of Hidradenitis Suppurativa in Women. Br. J. Dermatol. 1988;119(3):345–350.
- Melnik B. C., Plewig G. Impaired Notch-MKP-1 Signalling in Hidradenitis Suppurativa: an Approach to Pathogenesis by Evidence from Translational Biology. Exp. Dermatol. 2013;22(3):172–177.
- Zouboulis C. C., Desai N., Emtestam L. et al. European S1 Guideline for the Treatment of Hidradenitis Suppurativa/Acne Inversa. J. Eur. Acad. Dermatol. Venereol. 2015;29(4):619–644.
- Canoui-Poitrine F., Le Thuaut A., Revuz J. E. et al. Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study. J. Invest. Dermatol. 2013;133(6):1506–1511.
- Poli F., Wolkenstein P., Revuz J. Back and Face Involvement in Hidradenitis Suppurativa. Dermatology. 2010;221(2):137–141.
- Canoui-Poitrine F., Revuz J. E., Wolkenstein P. et al. Clinical Characteristics of a Series of 302 French Patients with Hidradenitis Suppurativa, with an Analysis of Factors Associated with Disease Severity. J. Am. Acad. Dermatol. 2009;61(1):51–57.
- Sartorius K., Lapins J., Emtestam L., Jemec G. B. Suggestions for Uniform Outcome Variables when Reporting Treatment Effects in Hidradenitis Suppurativa. Br. J. Dermatol. 2003;149(1):211–213.
- Freysz M., Jemec G. B., Lipsker D. A Systematic Review of Terms Used to Describe Hidradenitis Suppurativa. Br. J. Dermatol. 2015;173(5):1298–1300.
- Kimball A. B., Kerdel F., Adams D. et al. Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa: a Parallel Randomized Trial. Ann. Intern. Med. 2012;157(12):846–855.
- Grant A., Gonzalez T., Montgomery M. O. et al. Infliximab Therapy for Patients with Moderate to Severe Hidradenitis Suppurativa: a Randomized,
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).